Targeted sequencing reveals the relationship between mutations and patients’ clinical indicators, blood cell counts and early progression in diffuse large-B cell lymphoma

Guangyu MaDepartment of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaView further author information

Yuhuan GaoDepartment of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaView further author information

Xiaotong JingDepartment of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaView further author information

Cuiying HeDepartment of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaView further author information

Haisheng LiuDepartment of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaView further author information

Xiaolin WuDepartment of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaView further author information

Zhe GaoDepartment of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaView further author information

Yuan LiDepartment of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaView further author information

Shengnan ZhangDepartment of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaView further author information

Guimin ZhaoDepartment of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, ChinaCorrespondence[email protected]
View further author information

Your download is now in progress and you may close this window